Jennifer Laplante - Concepedia

Author

Jennifer Laplante

New York State Department of Health ORCID

Also Known As

Daryl Lamson, J. Laplante, Jennifer LaPlante, Jennifer Laplante, Jennifer M LaPlante, Jennifer M Laplante, Jennifer M. LaPlante, Jennifer M. Laplante

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

New York State Department of Health Wadsworth Center Centers for Disease Control and Prevention

About

Jennifer Laplante is an author at New York State Department of Health specializing in medicine, virology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	586
2	Public Health	2	2	102
3	Cell Biology	1	1	281
4	Cellular Therapies	1	1	281
5	Diabetes	1	1	281

Jennifer Laplante

Publications

650

Citations

H-Index

Page 1

	Year	Citations
Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes Seh‐Hoon Oh, Toni M Muzzonigro, Si–Hyun Bae, Laboratory Investigation Cell TherapyAdult BoneMedicineDiabetesImmunology	2004	281
Deep Sequencing Reveals Mixed Infection with 2009 Pandemic Influenza A (H1N1) Virus Strains and the Emergence of Oseltamivir Resistance Elodie Ghedin, Jennifer Laplante, Jay V. DePasse, The Journal of Infectious Diseases Mixed InfectionViral EvolutionNovo MutationVirus EpidemiologyVirus Strains	2010	113
Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States Samuel B. Graitcer, Larisa V. Gubareva, Laurie Kamimoto, Emerging infectious diseases Virus EpidemiologyClinical Infectious DiseaseMedicineClinical EpidemiologyVirus Transmission	2010	78
Next generation sequencing for whole genome analysis and surveillance of influenza A viruses Jana McGinnis, Jennifer Laplante, Matthew Shudt, Journal of Clinical Virology BioinformaticsInfluenza A VirusesNext GenerationViral EvolutionNext-generation Sequencing	2016	74
Influenza Antiviral Resistance Testing in New York and Wisconsin, 2006 to 2008: Methodology and Surveillance Data Jennifer Laplante, Steven A. Marshall, Matthew Shudt, Journal of Clinical Microbiology Virus EpidemiologyMolecular BiologyNew YorkAntiviral DrugSurveillance Data	2009	24
Cluster of Oseltamivir-Resistant and Hemagglutinin Antigenically Drifted Influenza A(H1N1)pdm09 Viruses, Texas, USA, January 2020 Teena Mohan, Ha Nguyen, Krista Kniss, Emerging infectious diseases	2021	24
Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance Margaret Okomo‐Adhiambo, Vasiliy P. Mishin, Katrina Sleeman, Antiviral Research VaccinationVirus EpidemiologyVirologyInfluenza Neuraminidase InhibitionDisease Surveillance	2016	16
Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir Mirella Salvatore, Jennifer Laplante, Rosemary Soave, Transplant Infectious Disease	2020	15
Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients Nenad Maćešić, Jennifer Laplante, Justin G. Aaron, Transplant Infectious Disease	2020	15
CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture Rama Ramani, Jennifer Laplante, Theresa M. Church, Journal of Virological Methods	2021	10

Page 1